Jonathan Bush - ModivCare Gen VP
| MODV Stock | USD 27.14 0.07 0.26% |
Insider
Jonathan Bush is Gen VP of ModivCare
| Age | 55 |
| Address | 6900 East Layton Avenue, Denver, CO, United States, 80237 |
| Phone | 303 728 7012 |
| Web | https://www.modivcare.com |
ModivCare Management Efficiency
Return On Tangible Assets is likely to climb to -0.31 in 2024. Return On Capital Employed is likely to drop to 0.03 in 2024. At this time, ModivCare's Total Assets are fairly stable compared to the past year. Other Assets is likely to climb to about 51.9 M in 2024, whereas Deferred Long Term Asset Charges is likely to drop slightly above 4.7 M in 2024. ModivCare's management efficiency ratios could be used to measure how well ModivCare manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Crissy Carlisle | Enhabit | 51 | |
| Thomas McEachin | Mednax Inc | 68 | |
| Rusty Yeager | Encompass Health Corp | N/A | |
| PT MBA | Enhabit | N/A | |
| Dan Peoples | Enhabit | N/A | |
| Michael Rucker | Mednax Inc | 51 | |
| Jennifer CPA | Pennant Group | 55 | |
| Roger Hinson | Mednax Inc | 57 | |
| Kevin Connor | Encompass Health Corp | 53 | |
| Guy Sansone | Mednax Inc | 56 | |
| Mary Moore | Mednax Inc | 63 | |
| Meghan Lublin | Mednax Inc | N/A | |
| RN MHA | InnovAge Holding Corp | 62 | |
| Tanya Marion | Enhabit | 49 | |
| BS MA | Enhabit | 56 | |
| Roger MD | Mednax Inc | 77 | |
| John Starcher | Mednax Inc | 50 | |
| L Shaw | Encompass Health Corp | 75 | |
| Maria Lozzano | InnovAge Holding Corp | 44 | |
| Derek Bunker | Pennant Group | 36 | |
| Brent Guerisoli | Pennant Group | 43 | |
Management Performance
| Return On Equity | -0.92 | ||||
| Return On Asset | 0.0095 |
ModivCare Leadership Team
Elected by the shareholders, the ModivCare's board of directors comprises two types of representatives: ModivCare inside directors who are chosen from within the company, and outside directors, selected externally and held independent of ModivCare. The board's role is to monitor ModivCare's management team and ensure that shareholders' interests are well served. ModivCare's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, ModivCare's outside directors are responsible for providing unbiased perspectives on the board's policies.
| CFA CFA, Associate Relations | ||
| Jessica Kral, Chief Officer | ||
| Heath Sampson, President, CEO | ||
| Ilias Simpson, President Mobility | ||
| Kenneth Shepard, Chief Mobility | ||
| LLM JD, Chief Officer | ||
| Walt Meffert, Chief Officer | ||
| Henry Toledo, Chief Officer | ||
| Barbara CPA, Chief Officer | ||
| Kevin Ellich, Head Relations | ||
| Kate Zerone, Director Communications | ||
| Grover Wray, Chief Officer | ||
| Nathan Vaughn, Chief Acquisition | ||
| Rebecca Orcutt, Senior Officer | ||
| Jonathan Bush, Gen VP |
ModivCare Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is ModivCare a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.92 | ||||
| Return On Asset | 0.0095 | ||||
| Profit Margin | (0.08) % | ||||
| Operating Margin | (0.01) % | ||||
| Current Valuation | 1.52 B | ||||
| Shares Outstanding | 14.21 M | ||||
| Shares Owned By Insiders | 1.36 % | ||||
| Shares Owned By Institutions | 98.64 % | ||||
| Number Of Shares Shorted | 1.05 M | ||||
| Price To Earning | 52.70 X |
Pair Trading with ModivCare
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if ModivCare position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ModivCare will appreciate offsetting losses from the drop in the long position's value.Moving together with ModivCare Stock
Moving against ModivCare Stock
| 0.53 | AVDL | Avadel Pharmaceuticals | PairCorr |
| 0.43 | PRGO | Perrigo Company | PairCorr |
| 0.43 | ANVS | Annovis Bio Earnings Call This Week | PairCorr |
The ability to find closely correlated positions to ModivCare could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace ModivCare when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back ModivCare - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling ModivCare to buy it.
The correlation of ModivCare is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as ModivCare moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if ModivCare moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for ModivCare can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for ModivCare Stock Analysis
When running ModivCare's price analysis, check to measure ModivCare's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ModivCare is operating at the current time. Most of ModivCare's value examination focuses on studying past and present price action to predict the probability of ModivCare's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ModivCare's price. Additionally, you may evaluate how the addition of ModivCare to your portfolios can decrease your overall portfolio volatility.